Traws Pharma’s Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR – BioSpace Poster underscores Tivoxavir Marboxil’s potential for the treatment of bird flu, supported by 100% survival in a rodent challenge model, … Read More at Source. Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook More Share on LinkedIn (Opens in new window) LinkedIn Share on Reddit (Opens in new window) Reddit Share on Tumblr (Opens in new window) Tumblr Share on Pinterest (Opens in new window) Pinterest Share on Telegram (Opens in new window) Telegram Share on WhatsApp (Opens in new window) WhatsApp Like this:Like Loading… Related Tags: BirdNews March 24, 2025 by Pumilo Bird News 0
